Day 1 Thursday, November 7 | ||
08:45-08:55 |
Opening |
Organizer's Remarks |
08:55-09:00 |
Chair |
Ekkehard Leberer, PhD |
09:00-09:45 |
Keynote |
Craig Mello, PhD, Professor, UMass Medical School, 2006 Nobel Prize in Physiology or Medicine, USA |
09:45-10:20 |
Understanding and Applying RNAi in Mammalian Cell Nuclei
David Corey, PhD, Rusty Kelley Professor of Medical Sciences, UT Southwestern Medical Center, USA | |
10:20-10:50 |
Refreshment Break & Poster Session | |
10:50-11:25 |
Driving in the Dark: Hunting for Long Noncoding RNAs in Cancer
Rory Johnson, PhD, Department of Medical Oncology, University Hospital of Bern, Switzerland | |
11:25-12:00 |
Biomimetic Chemistry of RNAi Therapeutics
Muthiah Manoharan, PhD, Senior Vice-President, Alnylam Pharmaceuticals, USA | |
12:00-13:30 |
Buffet Lunch | |
13:30-13:35 |
Chair |
Xiaohu Gao, PhD |
13:35-14:20 |
Special
Invited Talk |
Structural Biology of CRISPR-Cas Surveillance Complexes
Dinshaw Patel, PhD, Member of the American Academy of Arts and Sciences, USA |
14:20-14:55 |
|
Biological Robustness: Genetic Compensation and Transcriptional Adaptation
Didier Stainier, PhD, Director, Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, Germany |
14:55-15:25 |
Refreshment Break & Poster Session | |
15:25-16:00 |
|
Deciphering the ‘m6A code’ via Quantitative, Antibody Independent Mapping
Schraga Schwartz, PhD, Group leader, Department of Molecular Genetics, Weizmann Institute of Science, Israel |
16:00-16:35 |
|
Targeted Intracellular Delivery of siRNA
Xiaohu Gao, PhD, Professor of Bioengineering, University of Washington, USA |
16:35-16:55 |
Tech Report |
TBD |
16:55 |
End of Day 1 |
Day 2 Friday, November 8 | ||
08:55-09:00 |
Chair |
Muthiah Manoharan, PhD |
09:00-09:45 |
Keynote |
The Molecular Logic of Neural Circuit Formation
Thomas C. Südhof, M.D., Professor, Stanford University School of Medicine, 2013 Nobel Prize in Physiology or Medicine, USA |
09:45-10:20 |
|
MiRNA Therapeutics: From Discovery to the Bedside
Ekkehard Leberer, PhD, Senior Director of R&D Alliance Management, Sanofi, Germany |
10:20-10:50 |
Refreshment Break & Poster Session | |
10:50-11:25 |
Functional Characterization and Therapeutic Targeting of Gene Regulatory Elements
Nadav Ahituv, PhD, Professor, Institute for Human Genetics, University of California San Francisco, USA | |
11:25-11:45 |
Tech Report |
Manufacturing and Synthesis of Oligonucleotide Therapeutics from Process Development, through Clinical to Commercial Scale
TBD, GE Healthcare Biopharm, Sweden |
11:45-13:30 |
Buffet Lunch | |
13:30-13:35 |
Chair |
Bryan C. Dickinson, PhD |
13:35-14:10 |
The Role of tRNA Derived Small RNAs in Gene Regulation – A Potential Target for a New Cancer Therapeutic
Mark A. Kay, PhD, Professor, School of Medicine, Stanford University, USA | |
14:10-14:45 |
|
Humanized Synthetic Biology Approaches to Exploit RNA Regulation
Bryan C. Dickinson, PhD, Associate Professor of Chemistry, University of Chicago, USA |
14:45-15:20 |
|
Gene Regulation Mediated by Non-coding RNAs, RNA Binding Proteins and RNA Modifications
Gunter Meister, PhD, Professor and chair of Biochemistry, University of Regensburg, Germany |
15:20-15:55 |
|
Functions and Modes of Action of Long Noncoding RNAs in Mammalian Cells
Igor Ulitsky, PhD, Senior Scientist, Department of Biological Regulation, Weizmann Institute of Science, Israel |
15:55-16:20 |
Technology Report II
TBD | |
16:20-16:30 |
Closing |
Craig Mello, PhD, Professor, UMass Medical School, 2006 Nobel Prize in Physiology or Medicine, USA |